Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feliu

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Oncology|January 1, 1997
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breastJ Feliu, M González Barón, P Zamora, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2003
New insights in beta-tubulin sequence analysis in non-small cell lung cancerJ de Castro, C Belda-Iniesta, P Cejas, et al.
British Journal of Cancer|November 3, 2005
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancerJ Feliu, C Castañón, A Salud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
Recommendations and expert opinion on the adjuvant treatment of colon cancer in SpainJ M Vieitez, R García-Carbonero, J Aparicio, et al.
International Journal of Colorectal Disease|March 5, 2009
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapyV Moreno García, P Cejas, M Blanco Codesido, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 26, 2014
SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastasesM López-Gómez, J Moreno-Rubio, I Suárez-García, et al.
ESMO Open|April 22, 2023
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice GuidelineP Stone, P Buckle, R Dolan, et al.
British Journal of Cancer|April 29, 2010
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerJ Feliu, M J Safont, A Salud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 11, 2014
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?M López-Gómez, J Moreno-Rubio, I Suárez-García, et al.
British Journal of Cancer|March 23, 2006
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerJ Feliu, A Salud, P Escudero, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Oncology|January 1, 1997
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breastJ Feliu, M González Barón, P Zamora, et al.
Lung Cancer (Amsterdam, Netherlands)|June 27, 2003
New insights in beta-tubulin sequence analysis in non-small cell lung cancerJ de Castro, C Belda-Iniesta, P Cejas, et al.
British Journal of Cancer|November 3, 2005
Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancerJ Feliu, C Castañón, A Salud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
Recommendations and expert opinion on the adjuvant treatment of colon cancer in SpainJ M Vieitez, R García-Carbonero, J Aparicio, et al.
International Journal of Colorectal Disease|March 5, 2009
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapyV Moreno García, P Cejas, M Blanco Codesido, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 26, 2014
SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastasesM López-Gómez, J Moreno-Rubio, I Suárez-García, et al.
ESMO Open|April 22, 2023
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice GuidelineP Stone, P Buckle, R Dolan, et al.
British Journal of Cancer|April 29, 2010
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerJ Feliu, M J Safont, A Salud, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 11, 2014
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?M López-Gómez, J Moreno-Rubio, I Suárez-García, et al.
British Journal of Cancer|March 23, 2006
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerJ Feliu, A Salud, P Escudero, et al.
Pageof 15